[Type text]

GSK
GLAXOSMITHKLINE
Company Overview

A B-Gyan Initiave
bgyan21.nitie@gmail.com

Know Your Company

GSK GlaxoSmithKline

INTRODUCTION
GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical,
biologics, vaccines and consumer healthcare company headquartered in
London, United Kingdom. It is the world's fourth-largest pharmaceutical
company measured by prescription drug sales (after Pfizer, Novartis, and
Sanofi).
It was established in 2000 by the merger of Glaxo Wellcome plc (formed from
the acquisition of Wellcome plc by Glaxo plc) and SmithKline Beecham plc
laxoSmithKline plc. (GSK) is a British multinational pharmaceutical, biologics,
vaccines and consumer healthcare company headquartered in London, United
Kingdom. GSK Consumer Healthcare is a dominant player in nutritional
healthcare, oral healthcare and OTC medication.
GSK is one of the few healthcare companies researching both medicines and
vaccines for the World Health Organizations three priority diseases
HIV/AIDS, tuberculosis and malaria.
The Company produces medicines that treat major disease areas such as
asthma, anti-virals, infections, mental health, diabetes, cardiovascular and
digestive conditions. In addition, GSK is a leader in the important area of
vaccines and is developing new treatments for cancer.

COMPANY INFORMATION
In India GSK comprises of two separately listed companies:

GSK Consumer Healthcare (GSKCH)

Based in Gurgaon

GSK Pharmaceuticals

Based in Mumbai

A B-Gyan Initiative

Know Your Company

GSK GlaxoSmithKline

Founded

2000 Founded partnership

Head Quarters

London, United Kingdom

Leadership

Chris Gent (Chairman)

Andrew Witty (Chief Executive)

Industry

Pharmaceutical

Revenue

28.4 billion (2013)

Employees

97,389 (globally in 2013)

Global operations: Over 100 countries

Stock Listing: Primary - London Stock Exchange
Secondary New York Stock Exchange

FINANCIAL STATISTICS (FY 2012 13)

PRODUCTS CATEGORIES
Prescription medicines
The prescription medicines include treatments for a wide range of
conditions such as infections, depression, skin conditions, asthma, heart
and circulatory disease and cancer.
Vaccines
They market over 30 vaccines worldwide to prevent potentially lifethreatening or crippling illnesses such as hepatitis A, hepatitis B,

A B-Gyan Initiative

Know Your Company

GSK GlaxoSmithKline

diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio,

typhoid, influenza and bacterial meningitis.
Consumer Healthcare
GSK brings dental health products, over-the-counter medicines and
nutritional drinks to millions of people. Many of their brands, such as
Sensodyne, Panadol, Aquafresh, Lucozade and Nicorette/Niquitin are
familiar around the world.
Star Products in Nutritional Healthcare category: Boost, Maltova
Star Products in OTC category: ENO, Crocin and Iodex

PRODUCTS MARKETED BY GSK

over-the-counter (OTC) medicines including Gaviscon and Panadol

dental products such as Aquafresh and Sensodyne

smoking control products Nicorette/Niquitin

nutritional healthcare drinks such as Lucozade, Ribena and Horlicks

SALIENT FEATURES
GSK worldwide

A science-led global healthcare company

Employ over 97,000 people in over 100 countries
Around 12,500 people work in our research teams across the world to
discover new medicines
Vaccines are included in immunization campaigns in 182 countries
worldwide
Every second, GSK distributes more than 35 doses of Vaccines.
Every minute, more than 1100 prescriptions are written for GSK
products.
Every hour GSK spend more than 300,000 (US$562,000) to find new
medicines

GSK India

In India, GSK is one of the market leaders with a turnover of Rs. 2699
crore and a share of 4.2 percent

A B-Gyan Initiative

Know Your Company

GSK GlaxoSmithKline

GSK leads in several therapeutic segments - dermatology, antihelminthic, hormones

GSK has 5 products in the top 50 brands, and the top five GSK products
are Augmentin, Calpol, Zinetac, Betnesol and Ceftum
GSK's vaccines division is ranked second in a fast-growing vaccines
market. Some leading products in India are Varilrix, Havrix, Rotarix,
Cervarix and Engerix B
GSK India's R&D centers at Thane and Nashik have been granted
recognition by the Department of Scientific and Industrial Research,
Government of India.

SUPPLY CHAIN STRATEGY

GlaxoSmithKline is targeting improvements in its supply chain in the next
stage of its strategy to reduce its cost base, the company showing operating
profits up 42% to 3.8 billion, on sales 7.5% lower at 13.3 billion.
It its interim report GSK noted that: Working capital increased by 380 million
in the half-year, largely as a result of increased inventory holdings for seasonal
and new product stock-building. Consequently, working capital conversion
declined by 15 days compared with 31st December 2012.
The pharma giant is nearing the end of its current operational excellence
programme,which has focused on issues such as improving the selling model,
streamlining global manufacturing, enhancing research and development
efficiency, and reducing bureaucracy.

MARKETING STRATEGIES (4PS) OF HORLICKS

Product
Jr. Horlicks, Womens Horlicks, Mother Horlicks & Horlicks Lite.
Place
1800 wholesalers and direct coverage of over 4,00,000 retail outlets
South and Eastern markets which contributes about 46 per cent and 47 per
cent of the total sales
Price
Rs. 90/200gm & Rs. 170/500gm
A B-Gyan Initiative

Know Your Company

GSK GlaxoSmithKline

Less than competitor

Promotion
Horlicks has launched a fun and informative website (www.myhorlicks.com)
for kids (6-16) and mothers,
The brand also takes the medical platform by labeling the product as "Clinically
Proven ".

GSK IN NEWS
1. Women's Horlicks, a sub-brand of GlaxoSmithKline Consumer
Healthcare's flagship Horlicks milk drink, is now the consumergoods
company's fastest growing product with sales topping Rs 100 crore in
2013.
2. GlaxoSmithKline Consumer Healthcare Ltd, the maker of Horlicks and
Boost health food drinks, is looking at setting up a large manufacturing
facility close to the east coast in southern Andhra Pradesh.
3. GSK is scouting for about 100 acres of land at the two locations, apart
from connectivity to the natural gas grid, and has conveyed plans to
produce Foodles, which is its instant noodles product, biscuits and oats
under the Horlicks brand, apart from health food drinks.

A B-Gyan Initiative